The specific role of isoflavones in reducing prostate cancer risk. - Wikidata - awgldk - TriplyDB

The specific role of isoflavones in reducing prostate cancer risk.

The specific role of isoflavones in reducing prostate cancer risk.

http://www.wikidata.org/entity/Q34308510

about

Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality Nutritional translation blended with food science: 21st century applications Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.Recent progress on nutraceutical research in prostate cancer.Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures.Botanical medicine and cancer: a review of the safety and efficacy.Role of vitamins, minerals and supplements in the prevention and management of prostate cancer.Clinical trials of natural products as chemopreventive agents for prostate cancer.Isoflavones and Prostate Cancer: A Review of Some Critical Issues.A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.Safety of purified isoflavones in men with clinically localized prostate cancer A review of phase III clinical trials of prostate cancer chemoprevention.Soy isoflavone genistein in prevention and treatment of prostate cancer.Natural products for cancer prevention Dietary interventions in prostate cancer Perspectives on the role of isoflavones in prostate cancer.Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.Analytical and compositional aspects of isoflavones in food and their biological effects.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Risks and benefits of dietary isoflavones for cancer.Prostate cancer and diet: food for thought?Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.Does equol production determine soy endocrine effects?Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies.STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.Chemoprevention of prostate cancer: soy isoflavones and curcumin.A phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer.Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer.Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.

P2860

Q25256692-71BF035B-2672-427F-B1B0-5C7839DA527A Q26782066-91015D2D-18DA-41F6-A8DC-AEA17C615FA0 Q26849431-C02F6172-8390-469B-BDBF-6BF972136579 Q33710326-E79A1B5C-A859-40E3-8C54-8C021D0845A1 Q33757794-50ADCDE1-01AE-4172-94AF-B14F590C004A Q33818800-DEB75DCE-C6B5-45DB-9E9D-9CEF609E0EC9 Q34848018-A71E41E7-A7AD-4312-A521-46F399164575 Q34976272-30763208-B6DE-4D25-A7F4-8B060AC385B8 Q34992997-C83E8E4C-959F-42C8-AE64-2500E3AC3593 Q35196710-C079C866-E3F1-4707-8341-F4592CF01B6F Q35752245-FDFBBFCA-E2BC-48DE-BB4B-AF60462176AE Q35823852-BEB98EAB-930D-449E-89A1-8AC3E5CD4976 Q35967334-02713FB6-B484-479E-862A-47B8E57CB179 Q36414920-51C9BA1D-6337-4B6B-AF4F-10506647E9AE Q36600291-91ED143C-7B51-40FB-B05A-FD0941F6B039 Q36705608-8CF814BF-315F-4DAF-9529-E14C6325B6D3 Q36732271-3DB3FC65-EA26-4760-B387-7C68BEF2809C Q36741928-665EAED4-1BC1-47A4-A6A3-D66172B75E2C Q36774297-3C71A865-1892-473D-91D3-36B9CA68EC2E Q36965664-62F3A289-3CA7-4023-99D8-6AEB9BDE3C8E Q37109727-9F819639-E7FB-46B7-81CB-B92E730984CA Q37124666-21CAD500-00ED-4CE4-8855-F247E34617CF Q37207772-3D1F0293-6D08-4E4F-BBDD-467D025157D8 Q37442309-EA9366FD-CC27-478E-9817-F72969586D1B Q37576761-3C58DAF1-4F46-44E3-82F3-97B2509A5F0D Q37577822-A0C60472-BDE8-4D4C-9DE8-9519152C82D9 Q37602049-DA1513F0-4067-4C61-9910-FCF217D7C993 Q37654590-3F76F961-4ACE-482B-9C93-22E44E74EBF8 Q37857841-613B86D8-64C8-4121-813F-9D9B629198FD Q37868753-BD319312-61E6-4A1F-92E9-439DC7E84FED Q37944367-AA5080CA-49C5-41DE-81F5-AA4374016C40 Q37988309-717BA06A-EA48-4FF3-AD51-797FB9D5DFCA Q38245598-FC0ADDD5-EE0A-40CC-A152-87863AAC7EE7 Q38558029-CB322266-C0B7-4E85-84F1-AFFB779C86AD Q39023307-D8647010-8156-4986-BD51-E076940EA903 Q39913846-8FB774CB-5086-4DC7-B2FD-F7C7864E85DD Q41466203-3E2BD5CA-2CBF-40D0-8CD4-8743BEB39E63 Q43184865-6752DE13-6E2D-4CF8-A5A8-2DCAE1208211 Q44647635-B2D49753-657C-4F24-8FE1-6A7F9508439F Q47107153-0106132D-9D6F-47BE-873E-B050235AE748

P2860

The specific role of isoflavones in reducing prostate cancer risk.

http://www.wikidata.org/entity/Q34308510

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

The specific role of isoflavones in reducing prostate cancer risk.

@ast

The specific role of isoflavones in reducing prostate cancer risk.

@en

The specific role of isoflavones in reducing prostate cancer risk.

@nl

type

label

The specific role of isoflavones in reducing prostate cancer risk.

@ast

The specific role of isoflavones in reducing prostate cancer risk.

@en

The specific role of isoflavones in reducing prostate cancer risk.

@nl

prefLabel

The specific role of isoflavones in reducing prostate cancer risk.

@ast

The specific role of isoflavones in reducing prostate cancer risk.

@en

The specific role of isoflavones in reducing prostate cancer risk.

@nl

P1433

Q34308510-B082F708-568F-4978-BB53-023362FCA5DF

P1476

Q34308510-B0E932BA-31A5-418B-88A5-7888FDB92B6F

P2093

Q34308510-26A7AF9C-D996-4AFE-A171-71BCAB08906C

Q34308510-3260539C-DCF1-4889-897B-CFAE2E7AFFF7

Q34308510-4C867DE7-C2C6-4E0C-8156-E328056BB5F1

Q34308510-4D4021CD-C36B-440E-94D0-332E270C85F3

Q34308510-601D3077-81D7-497C-8C37-3548EDF96451

Q34308510-6455DC50-C5F4-48DC-8225-F410ACEE3379

Q34308510-A12E1BDC-6141-4AD0-8932-8A541F4B2E72

Q34308510-DF1FF5C4-7B30-40A4-87AC-71F338789461

Q34308510-E889B138-EB22-4444-9BFD-9FA252CCD898

P2860

Q34308510-25551849-20E7-4887-97AF-BD0BCA610A6E

Q34308510-E315FEA8-F4B8-47CF-861D-B794403738E0

P304

Q34308510-B211BE28-5B53-40A5-859D-0E81E0BF3F99

P31

Q34308510-38CEA4D1-7B74-4633-B2CD-8985AF853482

P356

Q34308510-49ACE4F6-8A3E-4A3A-AB36-F0D3CC5B5E6A

P433

Q34308510-F6DE42C9-3A11-4F4B-8856-19104E35C57E

P478

Q34308510-B4AA8102-9E2D-45D7-8FF9-0AECD89955A5

P577

Q34308510-B500AF73-E2A6-4E0E-86B6-860C3DD9089F

P698

Q34308510-2CCDCD5A-D95E-4387-B18B-7AE0E511FB31

P356

P1433

P1476

The specific role of isoflavones in reducing prostate cancer risk.

@en

P2093

Alan Cantor

http://www.w3.org/2001/XMLSchema#string

Diane Riccardi

http://www.w3.org/2001/XMLSchema#string

John Seigne

http://www.w3.org/2001/XMLSchema#string

Julio Pow-Sang

http://www.w3.org/2001/XMLSchema#string

Karen Besterman-Dahan

http://www.w3.org/2001/XMLSchema#string

Kathy Allen

http://www.w3.org/2001/XMLSchema#string

Mohamad Helal

http://www.w3.org/2001/XMLSchema#string

Nagi B Kumar

http://www.w3.org/2001/XMLSchema#string

Raoul Salup

http://www.w3.org/2001/XMLSchema#string

P2860

Stat3 activation is required for cellular transformation by v-src.

Phyto-oestrogens and Western diseases.

P304

141-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.10362

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15042614

http://www.w3.org/2001/XMLSchema#string